Joshua T Schiffer

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 51

Top Topics

Randomized Controlled Trial

Men Who Have Sex With Men

Top Venues

Nature communications

medRxiv : the preprint server for health sciences

Science advances

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy, low post-exposure prophylaxis efficacy, and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy. Nature communications 15 (1) (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy. Nature communications 15 (1) (2024)
Shuang Xu, Shadisadat Esmaeili, E Fabian Cardozo-Ojeda, Ashish Goyal, Judith M White, Stephen J Polyak, Joshua T Schiffer
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents. Antimicrobial agents and chemotherapy 68 (4) (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy, low post-exposure prophylaxis efficacy, and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Shuang Xu, Shadisadat Esmaeili, E Fabian Cardozo-Ojeda, Ashish Goyal, Judith M White, Stephen J Polyak, Joshua T Schiffer
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents. Antimicrobial agents and chemotherapy 68 (4) (2024)
Shuang Xu, Shadisadat Esmaeili, E Fabian Cardozo-Ojeda, Ashish Goyal, Judith M White, Stephen J Polyak, Joshua T Schiffer
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents. Antimicrobial agents and chemotherapy (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy. Nature communications 15 (1) (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy, low post-exposure prophylaxis efficacy, and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Shuang Xu, Shadisadat Esmaeili, E Fabian Cardozo-Ojeda, Ashish Goyal, Judith M White, Stephen J Polyak, Joshua T Schiffer
Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents. Antimicrobial agents and chemotherapy 68 (4) (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 15 (1) (2024)
Shadisadat Esmaeili-Wellman, Katherine Owens, Jessica Wagoner, Stephen J Polyak, Judith M White, Joshua T Schiffer
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound. medRxiv : the preprint server for health sciences (2024)
Daniel B Reeves, Christian Gaebler, Thiago Y Oliveria, Michael J Peluso, Joshua T Schiffer, Lillian B Cohn, Steven G Deeks, Michel C Nussenzweig
Impact of misclassified defective proviruses on HIV reservoir measurements. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Angela M Reiersen, Caline Mattar, Rachel Bender Ignacio, David R Boulware, Todd C Lee, Rachel Hess, Alexander J Lankowski, Emily Gibson McDonald, J Phillip Miller, William G Powderly, Matthew Flinn Pullen, Jeffrey T Rado, Michael W Rich, Joshua T Schiffer, Julie Schweiger, Adam M Spivak, Angela Stevens, Simone N Vigod, Payal Agarwal, Lei Yang, Michael Yingling, Torie R Gettinger, Charles F Zorumski, Eric J Lenze
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial. Open forum infectious diseases 10 (8) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Veronica A Davé, Laura E Richert-Spuhler, Tanvi Arkatkar, Lakshmi Warrier, Thepthara N Pholsena, Christine Johnston, Joshua T Schiffer, Martin Prlic, Jennifer M Lund
Recurrent infection transiently expands human tissue T cells while maintaining long-term homeostasis. The Journal of experimental medicine 220 (9) (2023)
Stefan Radtke, Mark R Enstrom, Dnyanada Pande, Elizabeth R Duke, Erwing Fabian Cardozo Ojeda, Ravishankar Madhu, Staci Owen, Greta Kanestrom, Margaret Lee Cui, Anai M Perez, Joshua T Schiffer, Hans-Peter Kiem
Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation. Blood (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Katherine Owens, Shadisadat Esmaeili-Wellman, Joshua T Schiffer
Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses. medRxiv : the preprint server for health sciences (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Charline Bacchus-Souffan, Mark Fitch, Mohamed Abdel-Mohsen, Rebecca Hoh, Haelee Ahn, Mars Stone, Frederick M Hecht, Jeffrey N Martin, Steven G Deeks, Marc K Hellerstein, Joseph M McCune, Joshua T Schiffer, Peter W Hunt
Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Joshua T Schiffer
The continuing puzzle of defining duration of SARS-CoV-2 infectivity. The Journal of infectious diseases (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, Yunda Huang, Bo Zhang, Lindsay N Carpp, Craig A Magaret, Michal Juraska, Peter B Gilbert, David C Montefiori, Katharine J Bar, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer, Raabya Rossenkhan, Paul T Edlefsen, Lynn Morris, Nonhlanhla N Mkhize, Carolyn Williamson, James I Mullins, Kelly E Seaton, Georgia D Tomaras, Philip Andrew, Nyaradzo Mgodi, Julie E Ledgerwood, Myron S Cohen, Lawrence Corey, Logashvari Naidoo, Catherine Orrell, Paul A Goepfert, Martín Casapía-Morales, Magdalena E Sobieszczyk, Shelly T Karuna, Srilatha Edupuganti
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nature communications 14 (1) (2023)
David A Swan, Morgane Rolland, Joshua T Herbeck, Joshua T Schiffer, Daniel B Reeves
Evolution during primary HIV infection does not require adaptive immune selection. Proceedings of the National Academy of Sciences of the United States of America 119 (7) (2022)
Bryan T Mayer, Allan C deCamp, Yunda Huang, Joshua T Schiffer, Raphaël Gottardo, Peter B Gilbert, Daniel B Reeves
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention. PLoS computational biology 18 (4) (2022)
Ashish Goyal, Matthew R Gardner, Bryan T Mayer, Keith R Jerome, Michael Farzan, Joshua T Schiffer, Erwing Fabian Cardozo Ojeda
Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission. Science advances 8 (2) (2022)
Erwing Fabian Cardozo Ojeda, Elizabeth R Duke, Christopher W Peterson, Daniel B Reeves, Bryan T Mayer, Hans-Peter Kiem, Joshua T Schiffer
Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation. eLife 10 (2021)
Catherine M Byrne, Christine Johnston, Jackson Orem, Fred Okuku, Meei-Li Huang, Habibur Rahman, Anna Wald, Lawrence Corey, Joshua T Schiffer, Corey Casper, Daniel Coombs, Soren Gantt
Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads. PLoS computational biology 17 (6) (2021)
Laura Matrajt, Holly E Janes, Joshua T Schiffer, Dobromir Dimitrov
Quantifying the Impact of Lifting Community Nonpharmaceutical Interventions for COVID-19 During Vaccination Rollout in the United States. Open forum infectious diseases 8 (7) (2021)
Danniel Zamora, Elizabeth R Duke, Hu Xie, Bradley C Edmison, Brenda Akoto, Richard Kiener, Terry Stevens-Ayers, Ralf Wagner, Marco B Mielcarek, Wendy M Leisenring, Keith R Jerome, Joshua T Schiffer, Greg Finak, Stephen C De Rosa, Michael J Boeckh
Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation. Blood 138 (1) (2021)
Ashish Goyal, Daniel B Reeves, E Fabian Cardozo-Ojeda, Joshua T Schiffer, Bryan T Mayer
Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events. eLife 10 (2021)
Sarah C Vick, Marie Frutoso, Florian Mair, Andrew J Konecny, Evan Greene, Caitlin R Wolf, Jennifer K Logue, Nicholas M Franko, Jim Boonyaratanakornkit, Raphaël Gottardo, Joshua T Schiffer, Helen Y Chu, Martin Prlic, Jennifer M Lund
A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections. Science advances 7 (46) (2021)
Charline Bacchus-Souffan, Mark D Fitch, Jori Symons, Mohamed Abdel-Mohsen, Daniel B Reeves, Rebecca Hoh, Mars Stone, Joseph Hiatt, Peggy Kim, Abha Chopra, Haelee Ahn, Vanessa A York, Daniel L Cameron, Frederick M Hecht, Jeffrey N Martin, Steven A Yukl, Simon A Mallal, Paul U Cameron, Steven G Deeks, Joshua T Schiffer, Sharon R Lewin, Marc K Hellerstein, Joseph M McCune, Peter W Hunt
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART. PLoS pathogens 17 (1) (2021)
Daniel B Reeves, Yunda Huang, Elizabeth R Duke, Bryan T Mayer, Erwing Fabian Cardozo Ojeda, Florencia A Boshier, David A Swan, Morgane Rolland, Merlin L Robb, John R Mascola, Myron S Cohen, Lawrence Corey, Peter B Gilbert, Joshua T Schiffer
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials. PLoS computational biology 16 (2) (2020)
Ashish Goyal, Erwing Fabian Cardozo Ojeda, Joshua T Schiffer
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response. Science advances 6 (47) (2020)
Joshua T Schiffer, Christine Johnston, Anna Wald, Lawrence Corey
An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2. Open forum infectious diseases 7 (7) (2020)
Shijie Cao, Sarah Danielle Slack, Claire N Levy, Sean M Hughes, Yonghou Jiang, Christopher Yogodzinski, Pavitra Roychoudhury, Keith R Jerome, Joshua T Schiffer, Florian Hladik, Kim A Woodrow
Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4+ T cell activation and HIV-1 latency reversal. Science advances 5 (3) (2019)
Daniel B Reeves, Amalia S Magaret, Alexander L Greninger, Christine Johnston, Joshua T Schiffer
Model-based estimation of superinfection prevalence from limited datasets. Journal of the Royal Society, Interface 15 (139) (2019)
Joshua T Schiffer, David A Swan, Martin Prlic, Jennifer M Lund
Herpes simplex virus-2 dynamics as a probe to measure the extremely rapid and spatially localized tissue-resident T-cell response. Immunological reviews 285 (1) (2019)